RecruitingPhase 2NCT06017869

Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)

Studying Pearson syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Minovia Therapeutics Ltd.
Intervention
MNV-201(biological)
Enrollment
6 enrolled
Eligibility
1-18 years · All sexes
Timeline
2023 – 2027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06017869 on ClinicalTrials.gov

Other trials for Pearson syndrome

Additional recruiting or active studies for the same condition.

See all trials for Pearson syndrome →

← Back to all trials